心脏瓣膜疾病临床数据平台
Published by:
DIGITAL CHINA HEALTH TECHNOLOGIES
Description
以多中心心脏二尖瓣智能临床研究为核心，学术引导智能驱动，流程化创建患者档案，结构化数据抓取，中心化数据录入，针对患者的术前、院中、院后进行高效的随访管理，更快速有效的帮助患者。
Screenshots
心脏瓣膜疾病临床数据平台 FAQ
-
Is 心脏瓣膜疾病临床数据平台 free?
Yes, 心脏瓣膜疾病临床数据平台 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 心脏瓣膜疾病临床数据平台 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 心脏瓣膜疾病临床数据平台 cost?
心脏瓣膜疾病临床数据平台 is free.
-
What is 心脏瓣膜疾病临床数据平台 revenue?
To get estimated revenue of 心脏瓣膜疾病临床数据平台 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Germany yet.
Ratings History
心脏瓣膜疾病临床数据平台 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
心脏瓣膜疾病临床数据平台 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
CHINA VALVE(HANGZHOU)
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
支架随访助手
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
水滴妙医(医生端)
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
参天临研园
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
LNRCT
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
随访专员
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
瓣你康
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
MedxingVet
宠物管理
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
MyGielly
|
Unlock
|
Unlock
|
0
|
|
11 months ago | |
肝胆医协医生端
|
Unlock
|
Unlock
|
0
|
|
10 months ago |
心脏瓣膜疾病临床数据平台 Installs
Last 30 days
心脏瓣膜疾病临床数据平台 Revenue
Last 30 days心脏瓣膜疾病临床数据平台 Revenue and Downloads
Gain valuable insights into 心脏瓣膜疾病临床数据平台 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- DIGITAL CHINA HEALTH TECHNOLOGIES
- Languages
- English
- Recent release
- 1.1.5 (4 months ago )
- Released on
- Dec 30, 2021 (2 years ago )
- Also available in
- Pakistan , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , India , Poland , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Denmark , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , China , Colombia , Czechia , Germany , United Arab Emirates , Dominican Republic , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel
- Last Updated
- 1 week ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.